Related references
Note: Only part of the references are listed.Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
An in vitro multistep carcinogenesis model for human cervical cancer
Mako Narisawa-Saito et al.
CANCER RESEARCH (2008)
BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer
Melinda M. Mortenson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Role of apoptotic regulators in human epithelial ovarian cancer
Rajarshi Kar et al.
CANCER BIOLOGY & THERAPY (2007)
Efficient immortalization of primary human cells by p16INK4a-specific short hairpin RNA or Bmi-1, combined with introduction of hTERT
Kei Haga et al.
CANCER SCIENCE (2007)
Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
Christopher P. Crum et al.
CLINICAL MEDICINE & RESEARCH (2007)
Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways
Rong Wu et al.
CANCER CELL (2007)
A mouse model for the molecular characterization of Brca1-associated ovarian carcinoma
Deyin Xing et al.
CANCER RESEARCH (2006)
Creation of tumorigenic human endometrial epithelial cells with intact chromosomes by introducing defined genetic elements
Y. Mizumoto et al.
ONCOGENE (2006)
Apoptosis-based therapies for hematologic malignancies
JC Reed et al.
BLOOD (2005)
Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability
T Maeda et al.
BRITISH JOURNAL OF CANCER (2005)
Functional analysis of PIK3CA gene mutations in human colorectal cancer
T Ikenoue et al.
CANCER RESEARCH (2005)
Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract
WJ Cheng et al.
NATURE MEDICINE (2005)
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer
DM Dinulescu et al.
NATURE MEDICINE (2005)
A genetically defined model for human ovarian cancer
JS Liu et al.
CANCER RESEARCH (2004)
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas
CY Hsu et al.
CLINICAL CANCER RESEARCH (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro
T Kusakari et al.
BRITISH JOURNAL OF CANCER (2003)
Evaluation of clinical significance of TP53, BCL-2, BAX and MEKI expression in 229 ovarian carcinomas treated with platinum-based regimen
J Kupryjanczyk et al.
BRITISH JOURNAL OF CANCER (2003)
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
S Orsulic et al.
CANCER CELL (2002)
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1
CM Eischen et al.
ONCOGENE (2001)
Combined analysis of p53 and RB pathways in epithelial ovarian cancer
Y Hashiguchi et al.
HUMAN PATHOLOGY (2001)
AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells
M Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen
M Nitta et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
